A new study by a team of 12 thoracic surgeons at Memorial Sloan Kettering Cancer Center (MSK), published recently in the ...

Along with defending against pathogens, the body’s innate immune system helps to protect the stability of our genomes in ...

Learn how molecular testing and an experimental targeted therapy cured jazz musician Michael Wolff, who had the rare cancer ...

Learn about the questions to ask a lung cancer doctor after being diagnosed, from an MSK specialist who has successfully ...

Learn about research at MSK that finds obesity can influence driver mutations that produce specific subtypes of cancers, ...

Multiplex immunofluorescence of a patient’s colorectal cancer liver metastasis showing the diversity of cell states from normal intestinal states (dark blue) to highly plastic injury repair (cyan) and ...

Read about a medical student treated at MSK for aggressive cervical cancer who later returned to train alongside MSK surgeons.

A research team led by MSK physician-scientist Dr. Piro Lito discovered that certain inhibitors can short-circuit the out-of-control signaling caused by mutations that fuel cancer growth. Each year, ...

Evidence from a recent study, led by MSK urologic surgeon, Behfar Ehdaie, MD, MPH, indicates that more patients with favorable Grade Group 2 prostate cancer can be successfully managed with active ...